Publications by authors named "Rumiko Matsushima"
Background: Japan became the world's first country to cover Helicobacter pylori eradication for chronic gastritis under its National Health Insurance (NHI) system in February 2013. Thereafter, H. pylori eradication dramatically increased and gastric cancer deaths began to decrease in Japan.
View Article and Find Full Text PDFArticle Synopsis
- Japan faces approximately 50,000 annual deaths from gastric cancer, primarily linked to Helicobacter pylori infections; eradication therapy was approved by national health insurance for chronic gastritis in 2013.
- A study analyzed the effects of this expanded coverage on gastric cancer death rates using a database from Hokkaido, Japan.
- Results showed a significant decline in gastric cancer deaths over four years, correlating with a dramatic increase in prescriptions for H. pylori eradication therapy following the insurance approval.
Helicobacter pylori Eradication to Eliminate Gastric Cancer: The Japanese Strategy.
Gastroenterol Clin North Am
September 2015
Helicobacter pylori eradication therapy for chronic gastritis achieved world-first coverage by the Japanese national health insurance scheme in 2013, making a dramatic decrease of gastric cancer-related deaths more realistic. Combining H pylori eradication therapy with endoscopic surveillance can prevent the development of gastric cancer. Even if it develops, most patients are likely to be diagnosed at an early stage, possibly resulting in fewer gastric cancer deaths.
View Article and Find Full Text PDF